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Oculomotor behavior and parameters are known to be affected by the allocation of attention and could
potentially be used to investigate attention disorders. We explored the oculomotor markers of Attention-
deﬁcit/hyperactivity disorder (ADHD) that are involuntary and quantitative and that could be used to
reveal the core-affected mechanisms, as well as be used for differential diagnosis. We recorded eye move-
ments in a group of 22 ADHD-diagnosed patients with and without medication (methylphenidate) and in
22 control observers while performing the test of variables of attention (t.o.v.a.). We found that the aver-
age microsaccade and blink rates were higher in the ADHD group, especially in the time interval around
stimulus onset. These rates increased monotonically over session time for both groups, but with signif-
icantly faster increments in the unmedicated ADHD group. With medication, the level and time course
of the microsaccade rate were fully normalized to the control level, regardless of the time interval within
trials. In contrast, the pupil diameter decreased over time within sessions and signiﬁcantly increased
above the control level with medication. We interpreted the suppression of microsaccades and eye blinks
around the stimulus onset as reﬂecting a temporal anticipation mechanism for the transient allocation of
attention, and their overall rates as inversely reﬂecting the level of arousal. We suggest that ADHD sub-
jects fail to maintain sufﬁcient levels of arousal during a simple and prolonged task, which limits their
ability to dynamically allocate attention while anticipating visual stimuli. This impairment normalizes
with medication and its oculomotor quantiﬁcation could potentially be used for differential diagnosis.
 2014 Elsevier Ltd. All rights reserved.1. Introduction
Attention deﬁcit hyperactivity disorder (ADHD) is a common
behavioral disorder with a genetic component (Guan et al.,
2009). The Diagnostic and Statistical Manual of Mental Disorders
(5th ed.; DSM-5) (American Psychiatric Association, 2013) describes
attention-deﬁcit/hyperactivity disorder as characterized by inat-
tention, impulsivity, and/or hyperactivity. These three subtypes
were found to be similar regarding the mean age, gender ratio,
prevalence, and pattern of associated learning disabilities, the fam-
ily history of psychopathology, and the probability of a favorable
response to methylphenidate (de Quiros et al., 1994). ADHD affects3–10% of children in the United States, one to two thirds of whom
will continue to suffer from this disorder throughout adulthood
(Wender, Wolf, & Wasserstein, 2001). A recent review concluded
that ‘‘The substantial societal burden of adult ADHD highlights
the importance of providing a better understanding of the factors
that contribute to accurate diagnosis and of improving the low
recognition of the disorder in many world regions’’ (Asherson
et al., 2012). Several computerized continuous performance tests
(CPT) aim to provide better diagnostics; the most used CPT is the
‘‘test of variables of attention’’ (t.o.v.a.) (Greenberg & Waldman,
1993). However, the reliability of t.o.v.a. as a screening diagnostic
tool is still debated (Zelnik et al., 2012).
Currently, the most effective treatment for ADHD is to use
medications containing the chemical compound methylphenidate
(MPH) (Arnsten, 2006). In general, psychostimulants such as
MPH have been found to be the most effective drugs for reducing
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Fig. 1. Stimuli. A ‘‘target’’ (left top) or ‘‘non-target’’ (left bottom) was presented for
100 ms every 2 s in random order, as demonstrated schematically on the right. The
size of the white square was 9.5  9.5 cm and the size of the inner black square was
1.2  1.2 cm, 0.7 cm from the edge of the white square. The viewing distance was
60 cm.
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with ADHD, and they can enhance speciﬁc aspects of cognitive per-
formance (Agay et al., 2010).
In recent years there has been an attempt to ﬁnd a reliable diag-
nostic tool based on physiological markers. One of the areas of
investigation is the visual system (Martin et al., 2008; Poltavski,
Biberdorf, & Petros, 2012), with a potential interest in the pattern
of microsaccades, as well as pupil dilation.
Microsaccades, which are small saccades associated with
visual ﬁxation, have been recently linked with attention, both in
space (biasing microsaccade direction) (Laubrock et al., 2010;
Pastukhov & Braun, 2010) and time (Pastukhov et al., 2012). In
response to perceptual events, microsaccades are typically inhib-
ited for a duration that depends on the stimulus parameters and
attention (Rolfs, 2009). Anticipated events are preceded by micro-
saccade inhibition (Betta & Turatto, 2006), and reaction times are
typically faster when microsaccades are inhibited around stimulus
onset (Kliegl et al., 2009). Moreover, higher attentional load is asso-
ciated with lower microsaccade rates (Pastukhov & Braun, 2010),
and attended as well as surprising stimuli induce prolonged
inhibition (Bonneh et al., 2011, 2012; Valsecchi, Betta, & Turatto,
2007). Although microsaccades have not been analyzed in ADHD
patients so far, one study found that these patients have
signiﬁcantly more saccades (>2) during prolonged ﬁxation in an
anti-saccade task (Munoz et al., 2003). The link between microsac-
cades and the allocation of attention was recently summarized in a
review (Martinez-Conde, Otero-Millan, & Macknik, 2013). In sum,
the pattern of microsaccadic response to perceptual stimuli as well
as the ongoing modulation of the microsaccade rate under
attentional demands could potentially be used to characterize
the variables of attention.
Blink rate has also been linked with mental states and attention,
suggesting a possible diagnostic value in ADHD patients. For exam-
ple, blink rates were found to be negatively correlated with arousal
(Tanaka, 1999) and increase with prolonged wakefulness (Barbato
et al., 2007), presumably due to a reduction in inhibitory control. In
line with these ﬁndings, a study of patients with chronic schizo-
phrenia found that the blink rates in free viewing were correlated
with signs of disinhibition (Chan & Chen, 2004).
Pupil diameter is another ocular parameter that has been
known for many years to correlate with mental activities
(Kahneman & Beatty, 1966), and it could also be used to measure
the level of arousal (Bradshaw, 1967). Apart from its main function,
which is to control the amount of light entering the eye, the pupil
diameter was also found to respond to a number of other factors.
The pupil dilates in response to increased activity of the sympa-
thetic system and constricts in response to increased parasympa-
thetic activity. Thus, any change in the balance between the two
systems will affect the pupil diameter. Drugs that change this bal-
ance, such as MPH, will also affect the diameter of the pupil
(Nagyova et al., 2007). Past studies showed that the pupil diameter
changes under various cognitive tasks (Kahneman & Wright, 1971;
Simpson, 1968). Similar to the microsaccade rate, although with a
different dynamics, the pupil diameter typically shows a transient
increase in response to perceptual events, with a magnitude and
time course that depends on various stimulus parameters such as
repetition and surprise (Privitera et al., 2010). Moreover, a recent
study found that ‘‘intentional changes in attentional spread’’ corre-
lated with changes in pupil diameter (Daniels et al., 2012).
Taken together, these studies show that different ocular param-
eters correlate with cognitive and attentional functions. The aim of
the current study was to investigate a possible difference in these
parameters between ADHD-diagnosed and control subjects in a
task that involves dynamic allocation of attention as opposed to
passive ﬁxation in which no difference was found between
ADHD-diagnosed and controlled subjects (Gould et al., 2001). Ouradditional aim was to investigate the effect of medication on these
parameters, and speciﬁcally whether it normalizes them as it
normalizes behavior.2. Methods
2.1. Participants
The participants consisted of 22 adult volunteers, mean age
33.9 ± 13.1, 12 males and 10 females, previously diagnosed
with ADHD, using DSM-IV-TR criteria (American Psychiatric
Association, 2000), and 22 control subjects, mean age 31.4 ± 8.5,
10 males, and 12 females. All the participants were tested in our
laboratory for visual acuity and were found to have normal or cor-
rected-to-normal vision. Except for one subject diagnosed with
additional Dysthymia and Social Anxiety, no other comorbidity
was diagnosed in the ADHD group. Each subject signed an
informed consent form approved by the local Institutional Review
Board of Sheba Medical Center.2.2. Medication
ADHD-diagnosed subjects had all previously been prescribed
medication containing methylphenidate, and all of them had taken
the medication before and reported that it increased their
performance in various daily activities. In our study, the subjects
were asked to take one dose of their individually prescribed
medication, which consisted of different formulations of methyl-
phenidate – Immediate release (IR Ritalin), OROS methylphenidate
(Concerta), and long-acting (Ritalin LA), and after 1.5 h of adminis-
tration, all formulations were found to have similar bioavailability
(McBurnett & Starr, 2011).2.3. Stimuli and procedure
A session consisted of a sequence of 648 trials, each consisting
of the commonly used t.o.v.a. stimuli presented for 100 ms every
2 s. A ‘‘target’’ and a ‘‘non-target’’ (see Fig. 1) consisted of a white
square of 9.5  9.5 cm (9  9 of visual angle) with an inner black
square of 1.2  1.2 cm (1.15  1.15), positioned 0.7 cm from the
top (for target) or bottom (for non-target) of the bright white
square. The luminance of the background, as well as of the small
inner square, was 0.2 CD/m2 and the luminance of the bright
square was 58 CD/m2. A small ﬁxation dot, 0.03 in diameter,
was constantly presented at the center of the display, with the
same luminance as the bright square. The stimuli were presented
in random order for about 22 min. In the ﬁrst half of the session
(the ‘‘rare’’ part) the target stimulus appeared randomly only for
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‘‘frequent’’ part) the target rate was 78%.
The stimuli were presented using an in-house-developed plat-
form for psychophysical experiments (PSY) developed by the third
author (YB) and were integrated with an eye tracking system. The
target stimuli were shown on a Brilliance 109P CRT display moni-
tor. The refresh rate was set to 100 Hz and the pixel resolution was
1024  768. The viewing distance was 60 cm in a darkened room.
Each subject performed the session twice in one day.
ADHD-diagnosed subjects performed the ﬁrst session before taking
the medication (which will be referred to as ‘‘ADHD’’), and per-
formed the session again 1.5 h after taking the medication
(‘‘ADHD-M’’). Control subjects also performed the session twice
with a 1.5 h break in between the sessions (which will be referred
to as ‘‘Control-1’’ and ‘‘Control-2’’, respectively). We have chosen
this same-day design to avoid across-days variability and also
owing to the difﬁculty in recruiting subjects for multiple days of
testing, which would have reduced our sample. Since there is a
long washout period for MPH, we used a ﬁxed order medication-
last design, and in order to control for possible carry-over effects
attributed to either learning or fatigue, the control subjects also
ran the session twice, with the same time gap between sessions.
Note that in a study that checked test–retest reliability, employing
the same inter-test gap of 1.5 h as we did, no signiﬁcant change
was found in reaction time (Leark, Wallace, & Fitzgerald, 2004).
The task was to respond as fast as possible to targets and to
ignore non-targets. The subjects were instructed to press the left
mouse button as fast as they can, without mistakes as much as pos-
sible, following the presentation of a target stimulus, and to ignore
non-target stimuli. Another instruction, which is not part of the
standard t.o.v.a., was to maintain ﬁxation on the ﬁxation dot at
the center of the screen.
2.4. Tracking eye movements
We recorded eye movements during the sessions with an
EyeLink 1000 desktop model from SR-Research. The subjects’
head was stabilized with a chin-rest. We tracked only the domi-
nant eye. Before each session we calibrated the system in order
to obtain an accurate gaze position. Eye tracking data were sam-
pled at 500 Hz and stored for ofﬂine analysis.
2.5. Data analysis
2.5.1. Blinks, microsaccades, and pupil diameter
Blinks were detected as periods of no tracking data. Microsac-
cades were detected by an algorithm developed by the ﬁrst author,
which was successfully used in another study (Bonneh et al.,
2010). Prior to microsaccade detection, the data were smoothed by
a low-pass ﬁlter with a cut-off frequency of 120 Hz. The algorithm
then detected sequences of data samples representing eye move-
ment for at least 6 ms in the same direction (with a 30 window),
with the minimum velocity, checked with each sample, exceeding
10/s, a peak velocity exceeding 18/s, and a saccade amplitude
greater than 0.1. Saccades with amplitudes >2 were ignored for
the main analysis. Dynamic overshoots, which are smaller ampli-
tude microsaccades that immediately follow a microsaccade in the
opposite direction, were counted together with the main microsac-
cade. Sections of blinks were excluded from saccade detection and
were considered as durations with no microsaccades. Furthermore,
to prevent false detection of microsaccades around blinks, we
excluded an additional 20 ms before and after each blink. Pupil
diameter data were taken at stimulus onset and converted intomil-
limeters using a conversion factor obtained by recording an artiﬁcial
eye, with a ﬁxed pupil diameter, in the same experimental setup. All
the trials in all the sessions were included in the analysis.2.5.2. Group averages and statistics
Group averages were computed and analyzed as follows. We
calculated, for each session, the average blink and microsaccade
rates for the entire trial duration and also during the peri-stimulus
interval only (100 to 150 ms relative to stimulus onset). Data for
target and non-target trials as well as for the ‘‘rare’’ and ‘‘frequent’’
halves of each session were pooled together for calculating group
averages because they showed no signiﬁcant difference in the
peri-stimulus interval. We then computed group averages for: (1)
ADHD, (2) ADHD-M, (3) Control-1, and (4) Control-2.
For statistical analysis of the group averages of microsaccade
and blink rates, the results were ﬁrst entered into ANOVA (2
groups  2 tests); pairwise comparisons were performed using
two-sample and paired t-tests, as speciﬁed. The degree of freedom
was 42 (2n  2) for the 2-sample t-test and 21 (n  1) for the
paired t-test.
2.5.3. Rate modulation in a trial
Microsaccade and blink rate modulation functions throughout
the trials, time-locked to stimulus onset, were computed as fol-
lows. In each trial, blinks (or microsaccades) were summed as
Gaussians with the center at the time of onset and with a sigma
of 20 ms to obtain a rate modulation function per trial. These rate
modulations were averaged per session and per subject, and then
averaged per group. Error bars were computed to reﬂect one stan-
dard error of the group mean at each data point. A similar method
was used successfully in a previous study (Bonneh et al., 2010) and
is used here for both microsaccades and blinks (see Fig. 10).
2.5.4. Time-course in a session
The time courses of microsaccade and blink rates as well as
pupil diameter across the 22 min sessions were computed as fol-
lows. Using a time bin of a single trial, respective rates were com-
puted for each trial in a session, averaged per observer and then
averaged by group to obtain standard error values. This procedure
was done twice: once for the peri-stimulus interval only and again
for the entire trial duration excluding the peri-stimulus time inter-
val (see Fig. 11).3. Results
The results are reported below; they are divided into separate
sections for each of the 3 ocular parameters investigated: blink
rate, microsaccade rate, and pupil diameter. Group averages were
computed across all the trial durations (2 s) or only during the
peri-stimulus time interval within each trial. Additional sections
summarize the time course of these parameters within a trial
and across the session as well as the effect of medication. We found
that the unmedicated ADHD group differed from the control group,
showing reduced suppression of microsaccades and blinks when
they had to be suppressed, and a recovery from these abnormali-
ties with medication.
3.1. Blink rate
Fig. 2 shows a raster plot of eye blinks during a t.o.v.a. session of
a sample unmedicated ADHD-diagnosed subject (a) and of a sam-
ple control subject (b). As can be clearly seen, there are no blinks in
the interval prior to, during, and shortly after stimulus presenta-
tion in the control subject, whereas there are many blinks in this
interval in the unmedicated ADHD subject. Fig. 3 shows the aver-
age blink rate of the four test groups throughout the session (a)
and only during the peri-stimulus interval (b). There was a signif-
icantly higher average blink rate in the ADHD group compared
with the control group, in both the ﬁrst and the second tests
Fig. 2. Eye blinks. Raster plot of eye blinks during a t.o.v.a. session of a sample unmedicated ADHD-diagnosed subject (a) and of a sample control subject (b). Each blue dot
represents the onset time of a single eye blink. The green bar represents the time interval of stimulus presentation. As shown, there are no blinks in the interval prior to,
during, and shortly after stimulus presentation in the control subject, whereas in the unmedicated ADHD subject there are many blinks during this interval. Furthermore, in
the control subject the blinks are highly synchronized with the stimulus presentation, whereas in the ADHD subjects the blinks are much less synchronized. (For
interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 3. Blink rates. Group averages of blink rates throughout the t.o.v.a. sessions (a) and for the peri-stimulus interval (b). The average blink rates of unmedicated ADHD
subjects throughout the session are signiﬁcantly higher than those of the control subjects and they are reduced towards a normal range for subjects with medication. The
blink rates of unmedicated ADHD subjects, checked only during the peri-stimulus interval, are signiﬁcantly higher than the rates of control subjects. This higher rate is
signiﬁcantly reduced to about half the rate of subjects with medication, but it still remains signiﬁcantly above the control rate.
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test effect: n.s, interaction: n.s.). As can be seen, the average blink
rate in the unmedicated ADHD group is signiﬁcantly higher than in
Control-1 (p = 0.033, two-sample t-test), with no signiﬁcant change
between Control-1 and Control-2 (p = 0.398) or medicated ADHD
and Control-2 (p = 0.255, two-sample t-test). In comparison, as
shown in Fig. 3 (b), unmedicated ADHD subjects failed to
synchronize their blinks to avoid blinking during an anticipated
stimulus presentation group effect: F(1,84) = 11.4, p = 0.001, test
effect: n.s., interaction: n.s. However, this capacity is signiﬁcantly
improved with medication (p = 0.034, paired t-test), and it still
remains above the control rate (p = 0.007) in the ﬁrst test and
approaches signiﬁcance (p = 0.069) in the second test, the two-
sample t-test.
Note that the average blink rates of all test groups were around
30 blinks/min, higher than a rate of 23/min, previously reported fornormal adults (Karson, 1983). This could be due to the subjects’
tendency to synchronize their blinks with the task in order to avoid
blinking during the anticipated stimulus presentation, as indicated
by the synchronized blink rate modulation (Figs. 2b and 10a), and
in line with the stimulus rate (30/min). This difference could also
be explained by the change in blink rate throughout the session
(Fig. 11e), starting at rates only slightly above 20 blinks/min for
the controls.
3.2. Microsaccade rate
Fig. 4 shows the microsaccades peak velocity–magnitude rela-
tionship, also known as the ‘‘main sequence’’, in a representative
ADHD and a control subject during the entire session. The data
show a similar main sequence and the amplitude range for the
two subjects; however, there were more microsaccades for the
Fig. 4. Saccade main sequence. The microsaccadic peak velocity–magnitude relationship in a representative (a) ADHD and (b) control subject, during one full session. Note
that both subjects exhibit a similar main sequence and amplitude range, although the ADHD subject has more microsaccades (N label in the plot).
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below. These data are consistent with the standard main sequence
effect in the literature, e.g. (McCamy et al., 2012).
Fig. 5 shows a raster plot of microsaccades during a t.o.v.a. ses-
sion of a sample unmedicated ADHD subject (a) and of a sample
control subject (b). As shown, few microsaccades were detected
in the interval prior to, during, and shortly after stimulus presenta-
tion in the control subject, whereas there were many microsac-
cades in this interval in the unmedicated ADHD subject.
Fig. 6 shows the average rates of microsaccades for the four test
groups throughout the session (a) and only during the peri-stimulus
interval (b). As shown, when microsaccade rates are averaged only
during the peri-stimulus interval, the rates in the unmedicatedFig. 5. Microsaccades. Raster plot of microsaccades during a t.o.v.a. session of a sample
blue dot represents the onset time of a single microsaccade. The green bar represents the
interval prior to, during, and shortly after stimulus presentation in the control subject,
interval. (For interpretation of the references to color in this ﬁgure legend, the reader isADHD group are signiﬁcantly higher than those in controls (group
effect: F(1,84) = 6.4, p = 0.014, test effect: F(1,84) = 6.5, p = 0.013,
interaction: F(1,84) = 5.2, p = 0.025). Moreover, the rates are
reduced in the medicated ADHD group (p = 0.001, paired t-test)
compared with the control group rates (p = n.s., two-sample t-test).
In addition, the average rate of microsaccades throughout the
t.o.v.a. session, in the unmedicated ADHD group, is signiﬁcantly
higher than in the control group (group effect: n.s., test effect:
F(1,84) = 7.9, p = 0.01, interaction: n.s.; p = 0.06, two-sample t-test).
This higher average rate is reduced to the average control rate with
medication (p < 0.001, paired t-test).
We further investigated the microsaccade rate differences
across groups, by examining their amplitude distributions. Theunmedicated ADHD-diagnosed subject (a) and of a sample control subject (b). Each
time interval of stimulus presentation. As shown, there are fewmicrosaccades, in the
whereas in the unmedicated ADHD subject there are many microsaccades in this
referred to the web version of this article.)
Fig. 6. Microsaccade rates. Average microsaccade rates for each of the four test groups. Throughout the t.o.v.a. sessions (a) the average rate of microsaccades in the
unmedicated ADHD group was signiﬁcantly higher than that of the control groups, and it was reduced to the normal range in the medicated group. The average microsaccade
rate in the unmedicated group during the peri-stimulus interval (b) was signiﬁcantly higher, almost threefold, than the rate of the control subjects. This higher rate was
reduced to the level of the control rates in the medicated group.
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microsaccades in the ADHD group in all the amplitude ranges,
but this difference is highest around 0.2.3.3. Manual reaction time
In order to verify that our microsaccade and blink rate measure-
ments are correlated with standard t.o.v.a. behavioral measure-
ments, we computed the average standard deviation of the
manual reaction time (RT-STD) for the four groups (which is the
main component of the t.o.v.a. score). Fig. 8 shows that both aver-
age RT and the average RT-STD was signiﬁcantly higher in the
unmedicated ADHD group compared with controls (p = 0.04 and
<0.001, RT and RT-STD, respectively, two-sample t-test), and that
it was reduced to the control level with medication (p = n.s. for
both RT and RT-STD, two-sample t-test).
We further investigated the correlation between the ocular
parameters (microsaccade and blink rates) and the manual
response time variability (RT-STD). The results are summarized
in Table 1, showing a signiﬁcant correlation for the microsaccade
rate in the peri-stimulus interval (MS-peri) for all groups, andFig. 7. Microsaccade amplitude distribution throughout the whole trial for each of
the four groups. Data were averaged per observer across all saccades within a trial,
divided into amplitude bins, and then averaged across all observers in the group.
Error sleeves denote 1SE across observers. Note that the main difference in the
unmedicated ADHD group lies in the small and frequent microsaccades around 0.2.especially for the ADHD groups (R > 0.5); however, there was a
lower but still signiﬁcant correlation for the blink rate only for
the ADHD groups (R around 0.3).
3.4. Pupil diameter
Fig. 9 shows the average pupil diameter and the average vari-
ability at the time of stimulus onset for the four conditions (group
and experiment). No signiﬁcant difference regarding the average
pupil diameter (Fig. 6a) was found between conditions (group
effect: n.s., test effect: n.s., interaction: n.s.), except for a small
effect of larger pupil diameter with medication (p = 0.041, paired
t-test). Pupil diameter variability (STD) did not differ signiﬁcantly
between groups in the ﬁrst test, or between the ﬁrst and second
test for the controls (Fig. 6b), but it was signiﬁcantly reduced with
medication (group effect: F(1,84) = 5.5, p = 0.022, test effect: n.s.,
interaction: F(1,84) = 4.1, p = 0.047), both compared with the test
before medication (p < 0.001, paired t-test) and with the second
test of the control group (p = 0.03, two-sample t-test). Additional
results related to the time course of pupil diameter modulation
throughout the session are described next.
3.5. Modulation of ocular parameters across time
We analyzed the time course of microsaccade and blink rates
within the 2 s trials, as well as the time course of all the ocular
parameters across the 22 min sessions.
3.5.1. Rate modulation within a trial
Fig. 10 shows the time course of the microsaccade and blink
rates within a trial. These functions were calculated per trial and
averaged across all target and non-target trials of both rare and fre-
quent session halves per observer, then averaged across all observ-
ers in each group (see Section 2). The general pattern of these time
courses, as shown for the controls, is a rate reduction that starts
before the anticipated stimulus onset and reaches almost a zero
rate about 100 ms after onset, followed by a release from inhibition
around 400–500 ms, and then a slow decrease towards the next
anticipated stimulus, which appears every 2 s. The ADHD group
deviates from the controls by (1) an elevated rate (both regarding
microsaccades and blinks) prior to and immediately after the
stimulus, but it failed to reach full suppression at around 100 ms;
Fig. 8. Manual reaction-times. Average manual reaction times (a) and the average standard deviation of the four groups (b). Both the average and the RT-STD were
signiﬁcantly higher in the unmedicated ADHD group compared with controls and were reduced to control levels with medication.
Table 1
Correlation between manual reaction times standard deviation (RT-STD) and the
main ocular parameters of microsaccade and blink rates. The correlation coefﬁcient R
was computed using individual subject data from each group, separately for the peri-
stimulus and the whole trial interval. Note the signiﬁcant correlation (R > 0.5) for the
microsaccade rate in the peri-stimulus interval for the ADHD groups and the lower
but still signiﬁcant correlation of the blink rate for these groups.
RT-STD vs. MS peri Blink peri MS total Blink total
ADHD 0.56 0.35 0.40 0.08
ADHD-M 0.66 0.26 0.60 0.09
Control-1 0.41 0.08 0.07 0.09
Control-2 0.39 0.04 0.07 0.25
Across groups 0.57 0.35 0.42 0.04
68 M. Fried et al. / Vision Research 101 (2014) 62–72(2) higher tonic rates after 1 s, with less anticipatory reduction
towards the next stimulus; (3) a delayed peak for the blink rate.
The results for the medicated ADHD group for microsaccades
appear to be very similar to those of the ﬁrst experiment using
the controls, and are identical regarding the initial suppression at
around 100 ms, i.e. the medicated ADHD patients showed normal
control over their microsaccades prior to and immediately after
the stimulus onset. Medication reduced also the blink rate, but to
a lesser extent and only during the period before stimulus onset.
These data are provided here for the purpose of qualitative com-
parison, and for pointing out the most informative time intervals,
which we investigated statistically via group averages.Fig. 9. Pupil diameter. Average pupil diameter of the four groups sampled at stimulus on
pupil diameter of the medicated ADHD group is higher than that of the control group, an
known physiological response to MPH. However, the variability of the pupil diameter
signiﬁcantly reduced in the ADHD group with medication.3.5.2. Rate modulation across the session
Fig. 11 shows the time course of the ocular parameters across
trials within the 22 min sessions. Group averages are plotted for
microsaccade rate, blink rate, and pupil diameter for two time
intervals in each trial: the peri-stimulus and post-stimulus
(Fig. 11, left and middle columns), as well as the ratio between
them (Fig. 11, right column). These plots show the ﬁndings of the
current study in more detail and point out the striking difference
in the ocular behavior of the unmedicated ADHD patients summa-
rized below and the striking normalizing effect of medication,
which will be described next.
The results can be summarized as follows: (1) Saccade and blink
rates show a similar general trend (Fig. 11, top and middle row).
They increase with time in the post-stimulus interval and are
lower for the peri-stimulus interval than for the post-stimulus
interval. This effect is strongest for the blink rate of the control
groups, where rates approach zero in the peri-stimulus interval
throughout the session (Fig. 11d). This was demonstrated by the
ratio plots (Fig. 11, right column), since the ratio values are all
below 1 (around 0.2 for the controls). (2) The unmedicated ADHD
group (Fig. 11, in red) shows a much higher tonic level of saccade
and blink rates than do the other groups throughout the trial,
possibly due to a lower level of arousal, which is necessary for
oculomotor inhibition. In addition, an interval-speciﬁc effect isset (a) and its standard deviation (b). Though statistically insigniﬁcant, the average
d is signiﬁcantly higher than before medication within the ADHD group, which is a
in the unmedicated group is about the same as in both control groups, but it is
Fig. 11. Ocular parameters’ modulation over time within a session. Group averages of 3 ocular parameters (rows) were computed in 2 time intervals within a trial (peri-
stimulus [100, 150], and post-stimulus [150, 1900] relative to stimulus onset), as well as the ratio between them (columns). The parameters shown are the saccade rate (a–
c), blink rate (d–f), and pupil size (g–i). The solid lines correspond to the different groups and conditions: ADHD, ADHD-M (with medication), C1 (controls, 1st session), and C2
(controls, 2nd session). Each point in the solid lines represents the group average for a trial in the session, with shaded areas showing ±1 SE of these averages. The x-axis
shows the trial number (1–648) corresponding to the 22 min sessions divided into ‘‘rare’’ and ‘‘frequent’’ halves (see Section 2) by different shades of gray. Note that all
parameters change with time across the session for all groups, increase (saccade and blink rates), or decrease (pupil size). The unmedicated ADHD group (in red) stands out
strikingly, especially for the saccade rate in the peri-stimulus interval, whereas the medicated ADHD group (in green) appears strikingly similar to the control groups for the
saccade and blink rates, but not for the pupil size. See the text for more details. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the
web version of this article.)
Fig. 10. Average blink (a) and microsaccade (b) rate modulation within trials, time locked to the stimulus onset (0), for each of the four groups. Data were averaged across all
trials, including targets and non-targets, for each observer, and then averaged across observers (N = 22) for each group, with error bars denoting 1SE of this average. Note the
higher microsaccade and blink rates in the ADHD group before and immediately after stimulus onset, and the full normalization effect of medication on microsaccades (b,
blue). (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
M. Fried et al. / Vision Research 101 (2014) 62–72 69demonstrated by the ratio plots (right column), showing more than
a twofold higher ratio for the unmedicated ADHD group compared
with controls, which implies a speciﬁc impairment in suppressing
saccades and blinks around the stimulus onset. (3) The pupildiameter decreased with time for all groups, possibly reﬂecting
adaptation to the task, which is accompanied by reduced vigilance
or arousal (Honda et al., 2013). (4) Following the change in target
frequency (‘‘rare’’ to ‘‘frequent’’) in the middle of the session, there
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Fig. 12. Differential diagnosis via a linear classiﬁcation of the microsaccade and
blink rates during the peri-stimulus interval. This preliminary attempt yields:
accuracy = 70%, sensitivity = 59%, speciﬁcity = 82%, and PPV = 76%. Note that both
the x and y-axes are plotted in logarithmic scale.
70 M. Fried et al. / Vision Research 101 (2014) 62–72was a decrease in the microsaccade and blink rates in both time
intervals and an increase in pupil diameter in all groups. These
changes reﬂect the effect of the additional attentional load and
effort owing to the change in the task.
3.6. The effect of medication
The results for the medicated ADHD group stand out as a strik-
ing effect of normalization, as found for microsaccade and blink
rates (Fig. 11, two upper rows, blue curves), and especially for
microsaccades. In Fig. 11a, the strong elevated microsaccade rate
of the unmedicated ADHD group (in red) is totally normalized to
the level of the controls (compare the blue curve to the black
and green curves). This could not be a re-test effect, because no
such effect was found between the two tests of the control group.
A similar normalization effect was found for the post-stimulus
interval (Fig. 11b) and hence for the ratio as well.
The medication effect on the blink rate is similar to that of the
microsaccades, but the normalization effect is only partial. In the
peri-stimulus interval (Fig. 11d), the medicated blink rate curve
(in blue) appears half way between the unmedicated group and
the controls. A smaller effect with the same trend was found for
the post-stimulus interval (Fig. 11e), possibly because the margin
for improvement with medication under that condition was small.
This is also reﬂected in the ratio plot (Fig. 11f), which shows a nor-
malization effect with medication despite very large variability.
However, a very different effect of medication was found
regarding the pupil diameter (Fig. 11g–i). As shown, the unmedi-
cated group had a slightly larger pupil diameter in the peri-stimu-
lus, but not in the post-stimulus interval. Not only was the pupil
size not normalized with medication, it even became larger in both
the peri- and post-stimulus intervals (compare the blue to the
other curves). This implies that the improvement in the inhibitory
power with medication, as demonstrated in the reduced microsac-
cade and blink rates around stimulus onset, had a cost – it was
achieved by elevating the general level of arousal signiﬁcantly
above normal, as reﬂected in the larger pupil diameter.
We considered the possibility that the presumed effect of med-
ication reﬂects a practice effect, not found in the control group due
to a ‘‘ﬂoor’’ effect (microsaccade and blink rates that had already
reached very low values in the ﬁrst session). One argument against
this possibility is the evidence for no test/retest effects in the
t.o.v.a. paradigm in terms of RT average and variability (Leark,
Wallace, & Fitzgerald, 2004), and our ﬁnding of a correlation
between microsaccade rates and manual RT variability. This
implies that the improvement in the medicated ADHD group is
unlikely to reﬂect the effect of practice.
To further investigate the suspected effect of practice, we
recalled 5 subjects from the ADHD group and had them run the
sessions twice without medication and with a gap of 1.5 h. We
found a slight deterioration rather than improvement of the
saccade rate (in the peri-stimulus interval) and of the manual RT
variability in the second recall run, compared with the ﬁrst, i.e.
no practice effect without medication. In addition, these results
showed no signiﬁcant difference from the ﬁrst (unmedicated)
recording in the main experiment. We therefore can conclude that
our measures reﬂect the true effect of medication, which is not due
to practice.
3.7. Using ocular parameters for diagnosis: preliminary results
In order to obtain a preliminary estimate for the classiﬁcation
power of our ocular parameters, we applied a simple linear classi-
ﬁcation approach to our sample, using the microsaccade and blink
rates in the peri-stimulus interval, where the difference between
the group averages was the largest. The results are shown inFig. 12, with rates converted to log units (log10(rate + 0.01)). This
preliminary classiﬁcation yielded an accuracy of 70%, a sensitivity
of 59%, a speciﬁcity of 82%, and a PPV of 76%. A better sensitivity
(79%), but lower speciﬁcity (76%), was obtained by using two
independent thresholds for the two parameters, combined with
an ‘‘and’’ operator.
4. Discussion
In looking for oculomotor markers that could be related to the
core deﬁcit in ADHD and that contribute to a more objective and
reliable diagnosis, we compared three oculomotor parameters
recorded during t.o.v.a. sessions. We compared the averages
between the unmedicated ADHD group and a control group, as
well as between the unmedicated and the medicated ADHD
groups. Our results show that unmedicated ADHD subjects have
signiﬁcantly higher rates of eye blinks and microsaccades, com-
pared with a control group (Figs. 3a and 6a), and that this effect
is largest in the peri-stimulus interval (Figs. 3b and 6b) where
eye movements should be suppressed because they could interfere
with the task. With medication, a striking effect of normalization
was found, with full normalization of the microsaccade rate in rela-
tion to the control level, and a partial normalization of blink rates,
mainly in the peri-stimulus interval (Figs. 3, 6, and 11).
4.1. ADHD and the inhibition of oculomotor activity
We hypothesized that in a task where subjects are required to
respond rapidly to visual targets that appear at a regular timing,
they will synchronize their transient allocation of attention with
the anticipated time of stimulus presentation. This should involve
suppression of oculomotor activities, which are known to interfere
with the visual input. In particular, we chose to analyze blinks and
saccades that involve similar mechanisms (Ridder & Tomlinson,
1997) and are known to prolong reaction times when occurring
during stimulus presentation (Johns et al., 2009). Since ADHD sub-
jects are known to be speciﬁcally impaired when sustaining their
attention in a continuous performance test, as expressed by their
typical high rates of false alarms and increased reaction time var-
iability (e.g. (Shalev et al., 2011)), we predicted that they would
exhibit lower suppression levels of both blinks and microsaccades
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study support our prediction. We found a signiﬁcantly higher aver-
age rate of both blinks and microsaccades (8-fold and 3-fold,
respectively) in the unmedicated ADHD group, compared with
the control groups in the peri-stimulus interval. With medication,
these rates were largely reduced, but only the microsaccade rates
reached normal levels. We can thus interpret the suppression of
microsaccades and blinks around stimulus onset as reﬂecting a
temporal anticipation mechanism for the transient allocation of
attention. Our results thus suggest that people with ADHD have a
speciﬁc impairment in the transient allocation of attention during
a continuous performance setting, which could be reduced with
medication. In line with this interpretation is a study that found
signiﬁcantly more saccades (>2) during prolonged ﬁxation in an
anti-saccade task in ADHD (Munoz et al., 2003), assuming that
microsaccades are just smaller saccades (Martinez-Conde, Otero-
Millan, & Macknik, 2013).
Our results regarding blink rate are in line with previous stud-
ies, which found blink rates to be negatively correlated with arou-
sal (Tanaka, 1999) and which increase with prolonged wakefulness
(Barbato et al., 2007). However, our results are inconsistent with a
previous study, which found lower than normal blink rates in
unmedicated children with ADHD in a verbal recall task, and
higher rates in these children taking medication (Caplan, Guthrie,
& Komo, 1996). These opposing results could be attributed to dif-
ferences in task and modality. In our experiments, subjects had
to suppress their eye blinks at the target onset to prevent missing
targets or by responding with a delay, and the ADHD subjects often
failed to do so.
4.2. ADHD and pupil diameter: light response, transient attention, and
arousal
The pupil diameter is known to be affected by three factors that
are relevant for the current study: (1) the light response, causing
constriction, (2) the transient allocation of attention during which
the pupil shows transient dilation (Privitera et al., 2010; Wierda
et al., 2012), and (3) the level of arousal, with a larger pupil size
reﬂecting increased arousal (Bradshaw, 1967).
The light response component is particularly strong in the
current study due to the very bright stimulus used in the t.o.v.a.
paradigm. Although it is impossible to dissociate it from the other
components in the current study, its effect can perhaps be appreci-
ated by comparing the pre and post-stimulus intervals (Fig. 11g
and h). This comparison yields a more pronounced effect in the
ADHD group with and without medication, as expressed by the
ratio (pre/post stimulus) plots (Fig. 11i). We intend to further
investigate and dissociate this effect in the future by removing it
using iso-luminance stimuli in an otherwise similar paradigm,
leaving its interpretation for the future.
An estimate of the transient allocation of attention and its efﬁ-
cacy in anticipating the target can perhaps be derived from the pupil
diameter and its variability at stimulus onset. We did not ﬁnd a sig-
niﬁcant difference in pupil diameter or its variability between
groups, but we found a larger pupil diameter (Figs. 9a, 11g and h)
and smaller variability (Fig. 9b) with medication. These results are
partially inconsistent with our expectation for pupil size expression
of a reduced anticipation effect in the ADHD group, as we found for
microsaccades and blinks. We noted, however, that such an expec-
tation is based on the assumption that the contribution of transient
attention to pupil diameter could be dissociated from the other
components, which is clearly not the case in the current data set.
On the other hand, the effect of medication is according to our
expectation, since it ﬁts the interpretation of enhancing transient
attention bymedication (a larger pupil at stimulus onsetwith lower
variability). Alternatively, it could be attributed to the effect ofmedication (MPH) on the balance between constriction and dilation
of the pupil at a physiological level (Jaanus, 1992). Finally, the pupil
diameter, which is known to be affected by the level of arousal
(Bradshaw, 1967), gives us an estimate of arousal, which is of partic-
ular importance in discussing the effect of medication (see below).
4.3. ADHD and medication: elevated arousal increases inhibitory
oculomotor control
One of the most striking ﬁndings of the current study is the nor-
malization effect of medication, i.e. the reduction of microsaccade
rates to control levels (Fig. 11a and b). In other words, medication
recovers inhibitory oculomotor control of the involuntary eye
movements. How is this achieved? One idea is that medication
affects a speciﬁc mechanism responsible for the transient alloca-
tion of attention to anticipated stimuli. These results suggest a dif-
ferent and more general explanation, derived from our results on
pupil diameter and microsaccade inhibition at the post-stimulus
interval. Since pupil diameter as well as microsaccades are known
to be affected by the level of arousal, with a larger pupil (Bradshaw,
1967) and a reduced microsaccades rate (Honda et al., 2013) for
higher arousal levels, and since medication consistently dilates
the pupil (Fig. 11g and h) and reduces microsaccade rates to
control levels (Fig. 11b), we suggest that medication increases
inhibitory oculomotor control by elevating the arousal level or
the general tonic level of the attention system, consequently
increasing the inhibitory power of the system.
4.4. The potential of oculomotor markers for differential diagnosis
In considering the current quantitative oculomotor measures
for a differential diagnosis of ADHD, we noted that although the
results are highly signiﬁcant in differentiating between the groups,
their diagnostic power at the individual level remains to be further
developed and optimized. The classiﬁcation we obtained (see Sec-
tion 3) should be regarded as preliminary and is probably lower
than the true potential of the ﬁndings. For example, the ADHD
group was not classiﬁed by severity or subtype, and the control
group was not screened to exclude ADHD. Therefore, we intend
to further investigate these parameters using a more controlled
paradigm with diagnosis and medication. Since only the ADHD
group was tested with medication, we could not take the observed
strong effect of medication as an additional diagnostic parameter,
which we believe would add much power to the classiﬁcation,
and this is left for future work.
Our results were obtained in experiments with the t.o.v.a. con-
tinuous performance test (CPT), known as a diagnostic tool for
ADHD, which is based primarily on response time variability
(Greenberg & Waldman, 1993). The t.o.v.a. paradigm was chosen
for its simplicity as a continuous performance paradigm that
utilizes a ﬁxed inter-stimulus-interval (ISI) during which we could
track the regularity and precision of the subjects’ oculomotor
activities. We also examined another CPT that utilizes variable
(random) ISI, the Conjunctive CPT (CCPT) developed by Tsal, Sha-
lev, & Mevorach (Shalev et al., 2011), but this paradigm did not
yield a similar difference between the groups. This suggests that
the ﬁxed timing is a critical property and that people with ADHD
have a speciﬁc impairment in the transient allocation of attention
for anticipated and regular events. We therefore expect similar
results in any continuous performance test with ﬁxed timing.5. Conclusions
Our study examined the ocular parameters of adults with
ADHD, including microsaccade rates, blink rates, and pupil dilation,
72 M. Fried et al. / Vision Research 101 (2014) 62–72while performing a continuous performance test. Our ﬁndings sug-
gest that unmedicated ADHD-diagnosed adults fail to suppress
both eye blinks and microsaccades when anticipating a visual tar-
get, and that medication improves this anticipatory mechanism.
The ocular measures examined in the current study and especially
the pattern of microsaccades, are largely involuntary and therefore
could potentially serve as an objective physiological marker for
diagnosing ADHD.
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